Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12


Double Trouble: The Diagnostic Dilemma of Diffuse Alveolar Hemorrhage.

Shagroni T, Baalwa J, Agarwal S.

Am J Med. 2016 Jul;129(7):e73-4. doi: 10.1016/j.amjmed.2016.02.040. Epub 2016 Mar 29. No abstract available.


Integrating Molecular Testing in the Diagnosis and Management of Children with Thyroid Lesions.

Ballester LY, Sarabia SF, Sayeed H, Patel N, Baalwa J, Athanassaki I, Hernandez JA, Fang E, Quintanilla NM, Roy A, López-Terrada DH.

Pediatr Dev Pathol. 2016 Mar-Apr;19(2):94-100. doi: 10.2350/15-05-1638-OA.1. Epub 2015 Sep 14.


Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV-1 recipients.

Yue L, Pfafferott KJ, Baalwa J, Conrod K, Dong CC, Chui C, Rong R, Claiborne DT, Prince JL, Tang J, Ribeiro RM, Cormier E, Hahn BH, Perelson AS, Shaw GM, Karita E, Gilmour J, Goepfert P, Derdeyn CA, Allen SA, Borrow P, Hunter E.

PLoS Pathog. 2015 Jan 8;11(1):e1004565. doi: 10.1371/journal.ppat.1004565. eCollection 2015 Jan.


Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity.

Veillette M, Désormeaux A, Medjahed H, Gharsallah NE, Coutu M, Baalwa J, Guan Y, Lewis G, Ferrari G, Hahn BH, Haynes BF, Robinson JE, Kaufmann DE, Bonsignori M, Sodroski J, Finzi A.

J Virol. 2014 Mar;88(5):2633-44. doi: 10.1128/JVI.03230-13. Epub 2013 Dec 18.


Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones.

Baalwa J, Wang S, Parrish NF, Decker JM, Keele BF, Learn GH, Yue L, Ruzagira E, Ssemwanga D, Kamali A, Amornkul PN, Price MA, Kappes JC, Karita E, Kaleebu P, Sanders E, Gilmour J, Allen S, Hunter E, Montefiori DC, Haynes BF, Cormier E, Hahn BH, Shaw GM.

Virology. 2013 Feb 5;436(1):33-48. doi: 10.1016/j.virol.2012.10.009. Epub 2012 Nov 1.


Chronic HIV infection affects the expression of the 2 transcription factors required for CD8 T-cell differentiation into cytolytic effectors.

Ribeiro-dos-Santos P, Turnbull EL, Monteiro M, Legrand A, Conrod K, Baalwa J, Pellegrino P, Shaw GM, Williams I, Borrow P, Rocha B.

Blood. 2012 May 24;119(21):4928-38. doi: 10.1182/blood-2011-12-395186. Epub 2012 Apr 6.


Escape is a more common mechanism than avidity reduction for evasion of CD8+ T cell responses in primary human immunodeficiency virus type 1 infection.

Turnbull EL, Baalwa J, Conrod KE, Wang S, Wei X, Wong M, Turner J, Pellegrino P, Williams I, Shaw GM, Borrow P.

Retrovirology. 2011 Jun 2;8:41. doi: 10.1186/1742-4690-8-41.


Prevalence of overweight and obesity in young adults in Uganda.

Baalwa J, Byarugaba BB, Kabagambe EK, Otim AM.

Afr Health Sci. 2010 Dec;10(4):367-73. Erratum in: Afr Health Sci.2011 Jun; 11(2):150. Kabagambe, KE [corrected to Kabagambe, EK]..


Multiple HIV-1 infections with evidence of recombination in heterosexual partnerships in a low risk Rural Clinical Cohort in Uganda.

Ssemwanga D, Lyagoba F, Ndembi N, Mayanja BN, Larke N, Wang S, Baalwa J, Williamson C, Grosskurth H, Kaleebu P.

Virology. 2011 Mar 1;411(1):113-31. doi: 10.1016/j.virol.2010.12.025. Epub 2011 Jan 15.


Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.

Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H, Decker JM, Wang S, Baalwa J, Kraus MH, Parrish NF, Shaw KS, Guffey MB, Bar KJ, Davis KL, Ochsenbauer-Jambor C, Kappes JC, Saag MS, Cohen MS, Mulenga J, Derdeyn CA, Allen S, Hunter E, Markowitz M, Hraber P, Perelson AS, Bhattacharya T, Haynes BF, Korber BT, Hahn BH, Shaw GM.

J Exp Med. 2009 Jun 8;206(6):1273-89. doi: 10.1084/jem.20090378. Epub 2009 Jun 1.


Worsening and unmasking of tuberculosis in HIV-1 infected patients after initiating highly active anti-retroviral therapy in Uganda.

Baalwa J, Mayanja-Kizza H, Kamya MR, John L, Kambugu A, Colebunders R.

Afr Health Sci. 2008 Sep;8(3):190-5.


Response to 'Does immune reconstitution promote active tuberculosis in patients receiving highly active antiretroviral therapy?' AIDS, 22 July 2005.

John L, Baalwa J, Kalimugogo P, Nabankema E, Castelnuovo B, Muhindo G, Colebunders R, Kambugu A.

AIDS. 2005 Nov 18;19(17):2049-50. No abstract available.


Supplemental Content

Loading ...
Support Center